Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1315

1.

Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.

Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, Magnuson JS, Spencer SA, Bonner JA.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):410-5. doi: 10.1016/j.ijrobp.2008.04.048. Epub 2008 Jul 16.

PMID:
18635320
[PubMed - indexed for MEDLINE]
2.

Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.

Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):403-9. doi: 10.1016/j.ijrobp.2009.02.017. Epub 2009 May 19.

PMID:
19467801
[PubMed - indexed for MEDLINE]
3.

Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.

Caglar HB, Tishler RB, Othus M, Burke E, Li Y, Goguen L, Wirth LJ, Haddad RI, Norris CM, Court LE, Aninno DJ, Posner MR, Allen AM.

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1110-8. doi: 10.1016/j.ijrobp.2008.02.048. Epub 2008 May 28.

PMID:
18468812
[PubMed - indexed for MEDLINE]
4.

Dysphagia following chemoradiation for locally advanced head and neck cancer.

Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett FA, Barloon J, Sallah S.

Ann Oncol. 2004 Mar;15(3):383-8. Review.

PMID:
14998839
[PubMed - indexed for MEDLINE]
Free Article
5.

Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.

Koiwai K, Shikama N, Sasaki S, Shinoda A, Kadoya M.

Jpn J Clin Oncol. 2009 Jul;39(7):413-7. doi: 10.1093/jjco/hyp033. Epub 2009 Apr 20.

PMID:
19383615
[PubMed - indexed for MEDLINE]
Free Article
6.

Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence.

Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Bhamidipati PV, Karlsson U, Nguyen PD, Alfieri A, Nguyen LM, Lemanski C, Chan W, Rose S, Sallah S.

Radiother Oncol. 2006 Sep;80(3):302-6. Epub 2006 Aug 4.

PMID:
16890314
[PubMed - indexed for MEDLINE]
7.

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ.

Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1060-5. doi: 10.1001/archotol.134.10.1060.

PMID:
18936351
[PubMed - indexed for MEDLINE]
8.

Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.

Dirix P, Abbeel S, Vanstraelen B, Hermans R, Nuyts S.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):385-92. doi: 10.1016/j.ijrobp.2008.11.041. Epub 2009 Jun 24.

PMID:
19553033
[PubMed - indexed for MEDLINE]
9.

Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.

Klem ML, Mechalakos JG, Wolden SL, Zelefsky MJ, Singh B, Kraus D, Shaha A, Shah J, Pfister DG, Lee NY.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1100-7. Epub 2007 Nov 5.

PMID:
17980501
[PubMed - indexed for MEDLINE]
10.

Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, Han HS, Markoe A.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1067-73.

PMID:
17967302
[PubMed - indexed for MEDLINE]
11.

Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett A, Barloon J, Sallah S.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):772-8.

PMID:
15708256
[PubMed - indexed for MEDLINE]
12.

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.

Büntzel J, Glatzel M, Kuttner K, Weinaug R, Fröhlich D.

Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):4-13.

PMID:
11917277
[PubMed - indexed for MEDLINE]
13.

Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.

Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1087-95.

PMID:
15752888
[PubMed - indexed for MEDLINE]
14.

Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.

Anand AK, Chaudhoory AR, Shukla A, Negi PS, Sinha SN, Babu AA, Munjal RK, Dewan AK, Kumar K, Doval DC, Vaid AK.

Br J Radiol. 2008 Nov;81(971):865-71. doi: 10.1259/bjr/31334499.

PMID:
18941046
[PubMed - indexed for MEDLINE]
15.

Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.

Franzmann EJ, Lundy DS, Abitbol AA, Goodwin WJ.

Head Neck. 2006 Aug;28(8):663-70.

PMID:
16783832
[PubMed - indexed for MEDLINE]
16.

Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.

Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, Newman K, Purdy JA, Vijayakumar S.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1026-32. doi: 10.1016/j.ijrobp.2009.09.036. Epub 2010 Mar 16.

PMID:
20231073
[PubMed - indexed for MEDLINE]
17.

Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J.

Clin Transl Oncol. 2007 Jan;9(1):40-7. Erratum in: Clin Transl Oncol. 2007 Mar;9(3):202.

PMID:
17272229
[PubMed - indexed for MEDLINE]
18.

Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma.

Smid L, Budihna M, Zakotnik B, Soba E, Strojan P, Fajdiga I, Zargi M, Oblak I, Dremelj M, LeSnicar H.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1055-62.

PMID:
12829141
[PubMed - indexed for MEDLINE]
19.

Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.

Finnegan V, Parsons JT, Greene BD, Sharma V.

Head Neck. 2009 Feb;31(2):167-74. doi: 10.1002/hed.20947.

PMID:
18853443
[PubMed - indexed for MEDLINE]
20.

Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer.

Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Nguyen PD, Nguyen LM, Dutta S, Lemanski C, Sallah S.

Oral Oncol. 2007 Apr;43(4):352-7. Epub 2006 Aug 22.

PMID:
16931114
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk